9.60

1.84% -0.18

AdvisorShares Pure US Cannabis ETF (MSOS)

Overview News Price History Option Chain Discussions Forecast Dividend History

AdvisorShares Pure US Cannabis ETF stock is currently priced at $9.60, with a 24-hour trading volume of 12.03M. It has seen a -1.84% decreased in the last 24 hours and a +0.84% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $9.96 pivot point. If it approaches the $9.41 support level, significant changes may occur.

Previous Close:

$9.78

Open:

$9.97

24h Volume:

12.03M

Market Cap:

$N/A

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+2.89%

1M Performance:

+0.84%

6M Performance:

+38.93%

1Y Performance:

+75.18%

1D Range:

$9.4176

$9.97

52W Range:

$4.78

$11.37

AdvisorShares Pure US Cannabis ETF Stock (MSOS) Company Profile

Name

AdvisorShares Pure US Cannabis ETF

Sector

Financial (4566)

Industry

Exchange Traded Fund (3096)

Phone

(202) 684-6383

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

MSOS's Discussions on Twitter

AdvisorShares Pure US Cannabis ETF Stock (MSOS) Latest News

Rescheduling Marijuana: How DOJ's Action Could Transform The Industry - AdvisorShares Trust AdvisorShares - Benzinga

Benzinga

Private Advisor Group LLC Sells 5821528 Shares of AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) - Defense World

Defense World

Cannabis Stocks CGC, TLRY, ACB, MSOS, CRON Pop as Justice Department Moves on Rescheduling - MSN

MSN

Cannabis rally sparks concerns amid moves to mainstream - MSN

MSN

Cannabis stocks rally after DOJ proposal to reclassify marijuana - MSN

MSN

Investors Buy Large Volume of Call Options on AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) - Defense World

Defense World

AdvisorShares Pure US Cannabis ETF Stock (MSOS) Financials Data

There is no financial data for AdvisorShares Pure US Cannabis ETF (MSOS). Check out other stocks for more information.

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.